Daniel N Swisher Jr Cerus Corp (CERS) insider trading activity

Daniel N Swisher Jr is Director of CERUS CORP. Currently has a direct ownership of 147,045 shares of CERS, which is worth approximately $230,860. The most recent transaction as insider was on Jun 05, 2024, when has been sold 40,000 shares (Common Stock) at a price of $5.0 per share, resulting in proceeds of $200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 147K

0% 3M change

40.65% 12M change

Total Value Held $230,860

Daniel N Swisher Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2024	BUY Grant, award, or other acquisition	$200,000 $5.0 p/Share	40,000 Added 21.39%	147,045 Common Stock
May 09 2024	BUY Open market or private purchase	$4,700 $1.88 p/Share	2,500 Added 2.28%	107,045 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	$200,000 $5.0 p/Share	40,000 Added 27.67%	104,545 Common Stock
May 26 2023	BUY Open market or private purchase	$9,550 $1.91 p/Share	5,000 Added 4.04%	118,808 Common Stock
Nov 10 2022	SELL Open market or private sale	$48,875 $3.91 p/Share	12,500 Reduced 9.9%	113,808 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$39,875 $3.19 p/Share	12,500 Added 9.01%	126,308 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	20,454 Added 15.23%	113,808 Common Stock
Aug 04 2021	SELL Open market or private sale	$80,481 $6.25 p/Share	12,877 Reduced 12.12%	93,354 Common Stock
Aug 04 2021	BUY Exercise of conversion of derivative security	$36,828 $2.86 p/Share	12,877 Added 10.81%	106,231 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	17,525 Added 15.81%	93,354 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	15,961 Added 17.39%	75,829 Common Stock
May 18 2021	SELL Open market or private sale	$28,750 $5.75 p/Share	5,000 Reduced 7.71%	59,868 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$14,500 $2.9 p/Share	5,000 Added 7.16%	64,868 Common Stock
Feb 16 2021	SELL Open market or private sale	$77,800 $7.78 p/Share	10,000 Reduced 14.31%	59,868 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$29,000 $2.9 p/Share	10,000 Added 12.52%	69,868 Common Stock
Nov 17 2020	SELL Open market or private sale	$62,500 $6.25 p/Share	10,000 Reduced 14.31%	59,868 Common Stock
Nov 17 2020	BUY Exercise of conversion of derivative security	$29,000 $2.9 p/Share	10,000 Added 12.52%	69,868 Common Stock

Also insider at

CORT

CORCEPT THERAPEUTICS INC Healthcare

JAZZ

Jazz Pharmaceuticals plc Healthcare

President and COO

PTGX

Protagonist Therapeutics, Inc Healthcare

Director

DNS